中药生物效应检测研究技术指导原则(征求意见稿)

2020-09-24 国家药品监督管理局药品审评中心(CDE) CDE

为提高中药质量可控性,鼓励研究探索中药生物效应检测方法,建立完善符合中药特点且关联临床疗效和安全性的质量评价与控制体系,我中心组织起草了《中药生物效应检测研究技术指导原则(征求意见稿)》。

中文标题:

中药生物效应检测研究技术指导原则(征求意见稿)

发布日期:

2020-09-24

简要介绍:

为提高中药质量可控性,鼓励研究探索中药生物效应检测方法,建立完善符合中药特点且关联临床疗效和安全性的质量评价与控制体系,我中心组织起草了《中药生物效应检测研究技术指导原则(征求意见稿)》。
       本指导原则的征求意见稿及起草说明(详见附件1、2)现在中心网站予以公示,以广泛听取各界意见和建议,欢迎各界提出宝贵意见和建议,并请及时反馈给我们。
       征求意见截止时间:2020年10月24日。
       您的反馈意见请发到以下邮箱:zyyxzdyz@cde.org.cn(“中药药学指导原则”拼音首字母)
       感谢您的参与和大力支持!
                                                                                                                           国家药品监督管理局药品审评中心
                                                                                                                                         2020年9月25日

相关资料下载:
[AttachmentFileName(sort=1, fileName=66.docx)] GetToolGuiderByIdResponse(projectId=1, id=cc7711c0019839cb, title=中药生物效应检测研究技术指导原则(征求意见稿), enTitle=, guiderFrom=CDE, authorId=0, author=, summary=为提高中药质量可控性,鼓励研究探索中药生物效应检测方法,建立完善符合中药特点且关联临床疗效和安全性的质量评价与控制体系,我中心组织起草了《中药生物效应检测研究技术指导原则(征求意见稿)》。, cover=, journalId=0, articlesId=null, associationId=1936, associationName=国家药品监督管理局药品审评中心(CDE), associationIntro=国家药品监督管理局药品审评中心(CDE), copyright=0, guiderPublishedTime=Thu Sep 24 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p>为提高中药质量可控性,鼓励研究探索中药生物效应检测方法,建立完善符合中药特点且关联临床疗效和安全性的质量评价与控制体系,我中心组织起草了《中药生物效应检测研究技术指导原则(征求意见稿)》。<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 本指导原则的征求意见稿及起草说明(详见附件1、2)现在中心网站予以公示,以广泛听取各界意见和建议,欢迎各界提出宝贵意见和建议,并请及时反馈给我们。<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 征求意见截止时间:2020年10月24日。<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 您的反馈意见请发到以下邮箱:zyyxzdyz@cde.org.cn(&ldquo;中药药学指导原则&rdquo;拼音首字母)<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 感谢您的参与和大力支持!<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 国家药品监督管理局药品审评中心<br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2020年9月25日</p>, tagList=[TagDto(tagId=11, tagName=中药)], categoryList=[CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指导原则, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1387, appHits=15, showAppHits=0, pcHits=278, showPcHits=1372, likes=1, shares=5, comments=3, approvalStatus=1, publishedTime=Fri Oct 02 19:53:34 CST 2020, publishedTimeString=2020-09-24, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Fri Oct 02 19:53:29 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 03:52:15 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.docx)])
66.docx
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=889751, encodeId=187c889e5125, content=很有用!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b9a5177216, createdName=146ebf5am09暂无昵称, createdTime=Fri Oct 02 20:43:52 CST 2020, time=2020-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889750, encodeId=30b8889e5014, content=很有用!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b9a5177216, createdName=146ebf5am09暂无昵称, createdTime=Fri Oct 02 20:42:39 CST 2020, time=2020-10-02, status=1, ipAttribution=)]
    2020-10-02 146ebf5am09暂无昵称

    很有用!!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=889751, encodeId=187c889e5125, content=很有用!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b9a5177216, createdName=146ebf5am09暂无昵称, createdTime=Fri Oct 02 20:43:52 CST 2020, time=2020-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889750, encodeId=30b8889e5014, content=很有用!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7b9a5177216, createdName=146ebf5am09暂无昵称, createdTime=Fri Oct 02 20:42:39 CST 2020, time=2020-10-02, status=1, ipAttribution=)]
    2020-10-02 146ebf5am09暂无昵称

    很有用!!

    0